STAFFORD, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating…Read More

You might also be interested in reading Blockchain Software Firm Consensys Acquires Mycrypto Ethereum Wallet.